首页> 外文OA文献 >A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities

【2h】

A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities

机译：除已知的抗肿瘤活性外，小分子药物YL529还抑制VEGF-D诱导的临床前肿瘤模型中的淋巴管生成和转移

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Youzhi Xu; Wenjie Lu; Peng Yang; Wen Peng; Chunting Wang; Manli Li; Yan Li; Guobo Li; Nana Meng; Hongjun Lin; Lixin Kan; Siying Wang; Shengyong Yang; Luoting Yu; YingLan Zhao;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities [J] . Youzhi Xu, Wenjie Lu, Peng Yang, BMC Cancer . 2015,第1期

机译：小分子药物YL529除其已知的抗肿瘤活性外，还抑制VEGF-D诱导的临床前肿瘤模型中的淋巴管生成和转移。
2. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities [J] . Youzhi Xu, Wenjie Lu, Peng Yang, BMC Cancer . 2015,第1期

机译：小分子药物YL529除其已知的抗肿瘤活性外，还抑制VEGF-D诱导的临床前肿瘤模型中的淋巴管生成和转移。
3. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model. [J] . Wen J, Fu AF, Chen LJ, International Journal of Cancer =: Journal International du Cancer . 2009,第11期

机译：脂质体纯粹抑制VEGF-D诱导的异种移植肿瘤模型中的淋巴管发生和转移。
4. Antitumor activity of DACHPt-loaded polymeric micelles against a bioluminescent lung metastasis tumor model [C] . Horacio Cabral, Nobuhiro Noshiyama, Kazunori Kataoka Controlled Release Society Annual Meeting and Exposition . 2007

机译：负载DACHPt的聚合物胶束对生物发光肺转移肿瘤模型的抗肿瘤活性
5. NAD(P)H:quinone oxidoreductase (NQO1)-directed lavendamycin antitumor agents: Structure-based design, molecular modeling and structure-activity studies [D] . Hassani, Mary 2007

机译：NAD（P）H：醌氧化还原酶（NQO1）指导的拉达霉素抗肿瘤剂：基于结构的设计，分子建模和结构活性研究
6. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities [O] . Youzhi Xu, Wenjie Lu, Peng Yang, 2015

机译：除已知的抗肿瘤活性外小分子药物YL529还抑制临床前肿瘤模型中VEGF-D诱导的淋巴管生成和转移
7. MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia models [O] . Douglas D. Fang, Qiuqiong Tang, Yanhui Kong, 2021

机译：MDM2抑制剂APG-115施加有效的抗肿瘤活性，并用临床前急性髓性白血病模型中的护理标准剂进行促进

A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities

著录项

引文网络

相似文献

相关主题

期刊订阅